Unknown

Dataset Information

0

Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism.


ABSTRACT: The natural killer (NK) group 2D (NKG2D) receptor, which displays on mouse and human NK cells, activates CD8+ T cells and small subsets of other T cells. NKG2D+CD8+ T cells play critical roles in both innate and adaptive immunity upon engagement with NKG2D ligands to eliminate tumor and infected cells. Despite the important role of NKG2D+CD8+ T cells in immune surveillance, the mechanisms of how NKG2D expression on CD8+ T cells is regulated remain poorly defined. We treated mouse and human CD8+ T cells with CD80 recombinant protein, plus a pharmacologic model with small molecular inhibitors to determine which signaling pathway leads to NKG2D regulation on CD8+T cells. This study revealed that CD28 activation gives rise to sustained NKG2D expression on both mouse and human CD8+ T cells in a signal transducer and activator of transcription 3 (STAT3) phosphorylation-dependent manner. Further, we found that CD28 activation stimulated sustained activation of the tyrosine kinase Lck, which recruits and triggers Janus kinase/STAT3 signaling to phosphorylate STAT3, and in turn increases NKG2D expression. Moreover, NKG2D induction on CD8+ T cells exerts cytolytic activity against target tumor cells in vitro, as well as significantly improves the antitumor therapeutic effects in vivo in an NKG2D-dependent manner. Taken together, these results elucidated a novel mechanism of NKG2D regulation by phosphorylated STAT3 (pSTAT3) on CD8+ T cells upon CD28 activation. This mechanism may shed light on the effectiveness of CD80-based, NKG2D-dependent antitumor immunotherapy.

SUBMITTER: Hu J 

PROVIDER: S-EPMC5214668 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of NKG2D<sup>+</sup>CD8<sup>+</sup> T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism.

Hu Jiemiao J   Batth Izhar S IS   Xia Xueqing X   Li Shulin S  

Oncoimmunology 20161101 12


The natural killer (NK) group 2D (NKG2D) receptor, which displays on mouse and human NK cells, activates CD8<sup>+</sup> T cells and small subsets of other T cells. NKG2D<sup>+</sup>CD8<sup>+</sup> T cells play critical roles in both innate and adaptive immunity upon engagement with NKG2D ligands to eliminate tumor and infected cells. Despite the important role of NKG2D<sup>+</sup>CD8<sup>+</sup> T cells in immune surveillance, the mechanisms of how NKG2D expression on CD8<sup>+</sup> T cells is  ...[more]

Similar Datasets

| S-EPMC8134507 | biostudies-literature
| S-EPMC5560431 | biostudies-literature
| S-EPMC8449782 | biostudies-literature
| S-EPMC8409295 | biostudies-literature
| S-EPMC9408754 | biostudies-literature
| S-EPMC8591704 | biostudies-literature
| S-EPMC8102368 | biostudies-literature
| S-EPMC5507973 | biostudies-literature
| S-EPMC8018994 | biostudies-literature